{
    "fund_name": "iShares iBonds Dec 2026 Term $ CorpUSD (Dist)",
    "type": "ETF",
    "ucits": true,
    "replication_method": "physical",
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "complex_factors": [
        "Term structure with mandatory redemption in 2026",
        "ESG screening criteria may reduce investment universe",
        "Securities lending activities",
        "Defined term fund with changing risk profile over time"
    ],
    "classification": "non-complex",
    "supporting_data": "The ETF uses physical replication to track the Bloomberg MSCI December 2026 Maturity USD Corporate ESG Screened Index. There is no mention of synthetic replication, swaps, or leverage. The primary complexity factors are the term structure (mandatory redemption in 2026) and the ESG screening criteria, which may reduce the investment universe. The fund engages in securities lending to offset costs, but this is a common practice in many ETFs and does not inherently make the product complex. The risk profile is rated 3/7, indicating moderate risk, and the fund is designed for investors who can hold until maturity. The absence of derivatives, leverage, or inverse strategies, combined with the physical replication method, supports a non-complex classification under MiFID II.",
    "confidence": 90,
    "counter_argument": "Some may argue that the term structure and mandatory redemption could make the fund complex, but the straightforward physical replication and lack of derivative exposure outweigh these factors. The ESG screening is transparent and does not introduce significant complexity.",
    "overriding_reason": "The fund's primary complexity factors (term structure and ESG screening) do not meet the MiFID II thresholds for complexity, as they do not involve derivatives, leverage, or opaque structures. The physical replication method and moderate risk profile further support the non-complex classification."
}